KHAMPHOU MOSLEY: Open Payments
NPI 1093205049 · OKEECHOBEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 12 payments from 10 companies in 2025. Trend: 2023 $350 · 2024 $403 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $47 |
| Novo Nordisk Inc | 2 | $44 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: The Cologuard Plus Collection Kit, TARPEYO, SHINGRIX, REXULTI, FREESTYLE LIBRE 3, Ozempic, XIFAXAN, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
